Invasive cutaneous fungal infections requiring radical resection in cancer patients undergoing chemotherapy

Ravi Radhakrishnan, Michele L. Donato, Victor G. Prieto, Steven R. Mays, Issam I. Raad, Henry M. Kuerer

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Invasive fungal infections have emerged as a significant problem in patients with cancer with the development of better systemic therapies for malignancy and more effective antibacterial agents. The currently available world published medical literature was reviewed on invasive fungal infections in cancer patients with specific attention devoted to the multidisciplinary role of surgery in refractory cutaneous cases. Infections can develop on the forearm where peripheral intravenous catheters had been inserted in cancer patients undergoing cytotoxic chemotherapy. Curative intent begins with systemic contemporary anti-fungal therapy. Following resolution of neutropenia, patients may require radical surgical debridement with negative margins of resection for complete eradication of the fungal infection. Although invasive fungal infections refractory to antifungal systemic therapy in immunocompromised patients undergoing chemotherapy are a rare event, it is critical for surgeons and other multidisciplinary clinicians to recognize these potentially life-threatening infections that may necessitate radical surgical resection for cure.

Original languageEnglish (US)
Pages (from-to)21-26
Number of pages6
JournalJournal of Surgical Oncology
Volume88
Issue number1
DOIs
StatePublished - Oct 1 2004
Externally publishedYes

Fingerprint

Drug Therapy
Skin
Neoplasms
Mycoses
Immunocompromised Host
Debridement
Infection
Neutropenia
Forearm
Therapeutics
Catheters
Anti-Bacterial Agents
Invasive Fungal Infections
Surgeons
Margins of Excision

Keywords

  • Aspergillosis
  • Chemotherapy
  • Fasciitis
  • Mucormycosis
  • Surgery

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Invasive cutaneous fungal infections requiring radical resection in cancer patients undergoing chemotherapy. / Radhakrishnan, Ravi; Donato, Michele L.; Prieto, Victor G.; Mays, Steven R.; Raad, Issam I.; Kuerer, Henry M.

In: Journal of Surgical Oncology, Vol. 88, No. 1, 01.10.2004, p. 21-26.

Research output: Contribution to journalArticle

Radhakrishnan, Ravi ; Donato, Michele L. ; Prieto, Victor G. ; Mays, Steven R. ; Raad, Issam I. ; Kuerer, Henry M. / Invasive cutaneous fungal infections requiring radical resection in cancer patients undergoing chemotherapy. In: Journal of Surgical Oncology. 2004 ; Vol. 88, No. 1. pp. 21-26.
@article{6f539ad812a94749bc222704caf68ad0,
title = "Invasive cutaneous fungal infections requiring radical resection in cancer patients undergoing chemotherapy",
abstract = "Invasive fungal infections have emerged as a significant problem in patients with cancer with the development of better systemic therapies for malignancy and more effective antibacterial agents. The currently available world published medical literature was reviewed on invasive fungal infections in cancer patients with specific attention devoted to the multidisciplinary role of surgery in refractory cutaneous cases. Infections can develop on the forearm where peripheral intravenous catheters had been inserted in cancer patients undergoing cytotoxic chemotherapy. Curative intent begins with systemic contemporary anti-fungal therapy. Following resolution of neutropenia, patients may require radical surgical debridement with negative margins of resection for complete eradication of the fungal infection. Although invasive fungal infections refractory to antifungal systemic therapy in immunocompromised patients undergoing chemotherapy are a rare event, it is critical for surgeons and other multidisciplinary clinicians to recognize these potentially life-threatening infections that may necessitate radical surgical resection for cure.",
keywords = "Aspergillosis, Chemotherapy, Fasciitis, Mucormycosis, Surgery",
author = "Ravi Radhakrishnan and Donato, {Michele L.} and Prieto, {Victor G.} and Mays, {Steven R.} and Raad, {Issam I.} and Kuerer, {Henry M.}",
year = "2004",
month = "10",
day = "1",
doi = "10.1002/jso.20115",
language = "English (US)",
volume = "88",
pages = "21--26",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Invasive cutaneous fungal infections requiring radical resection in cancer patients undergoing chemotherapy

AU - Radhakrishnan, Ravi

AU - Donato, Michele L.

AU - Prieto, Victor G.

AU - Mays, Steven R.

AU - Raad, Issam I.

AU - Kuerer, Henry M.

PY - 2004/10/1

Y1 - 2004/10/1

N2 - Invasive fungal infections have emerged as a significant problem in patients with cancer with the development of better systemic therapies for malignancy and more effective antibacterial agents. The currently available world published medical literature was reviewed on invasive fungal infections in cancer patients with specific attention devoted to the multidisciplinary role of surgery in refractory cutaneous cases. Infections can develop on the forearm where peripheral intravenous catheters had been inserted in cancer patients undergoing cytotoxic chemotherapy. Curative intent begins with systemic contemporary anti-fungal therapy. Following resolution of neutropenia, patients may require radical surgical debridement with negative margins of resection for complete eradication of the fungal infection. Although invasive fungal infections refractory to antifungal systemic therapy in immunocompromised patients undergoing chemotherapy are a rare event, it is critical for surgeons and other multidisciplinary clinicians to recognize these potentially life-threatening infections that may necessitate radical surgical resection for cure.

AB - Invasive fungal infections have emerged as a significant problem in patients with cancer with the development of better systemic therapies for malignancy and more effective antibacterial agents. The currently available world published medical literature was reviewed on invasive fungal infections in cancer patients with specific attention devoted to the multidisciplinary role of surgery in refractory cutaneous cases. Infections can develop on the forearm where peripheral intravenous catheters had been inserted in cancer patients undergoing cytotoxic chemotherapy. Curative intent begins with systemic contemporary anti-fungal therapy. Following resolution of neutropenia, patients may require radical surgical debridement with negative margins of resection for complete eradication of the fungal infection. Although invasive fungal infections refractory to antifungal systemic therapy in immunocompromised patients undergoing chemotherapy are a rare event, it is critical for surgeons and other multidisciplinary clinicians to recognize these potentially life-threatening infections that may necessitate radical surgical resection for cure.

KW - Aspergillosis

KW - Chemotherapy

KW - Fasciitis

KW - Mucormycosis

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=4744342920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4744342920&partnerID=8YFLogxK

U2 - 10.1002/jso.20115

DO - 10.1002/jso.20115

M3 - Article

C2 - 15384060

AN - SCOPUS:4744342920

VL - 88

SP - 21

EP - 26

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 1

ER -